Multicenter HomeVENT: Home Values and Experiences Navigation Track
Johns Hopkins University · with Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · NCT06102330
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 600
- US sites recruiting
- 4
- Study start
- February 6, 2024
- Record last updated
- July 16, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This is a multicenter study to test a decision-making support process for families and clinicians facing decisions about chronic home ventilation for a child. The investigators hypothesize that the intervention will increase family preparedness for decision-making and will improve clinician-family shared-decision making. Half of families will be assigned to "usual care" arm and half to the "intervention" arm. Intervention families will view the study website with study staff and will answer questions related to website content. All families will be interviewed and surveyed at 1, 6 and 12 months after enrollment. Each family will designate 1-2 physician involved in the decision about home ventilation; each physician will be interviewed and surveyed at 1 month.
Being studied: HomeVENT decision support tool
Conditions: Pediatric ALL; Respiratory Insufficiency; Communication
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- English- or Spanish-speaking
- Males and females; Age 18 and over.
- Parent of a child facing a decision about home ventilation within 30 days. A "parent" will be defined as any self-identified primary caregiver (parents, grandparents, etc).
or Physician of a child whose parents are enrolled in the study; physician must be engaged in the home ventilation decision.
- Provision of signed and dated informed consent form (parent) or completion of oral consent (physician)
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Access to necessary resources if choose to participate via internet or telephone
Exclusion Criteria
- Excluding children as they cannot be legal decision-makers
- Non-English or Non-Spanish speaking parents, as the intervention website/ videos are only available in those two languages.
Recruiting US locations
Johns Hopkins All Childrens Hospital
Tampa, FL 33701
Site contact: Nicholas Jabre, MD · 717-215-6522 · njabre1@jhmi.edu
Children's Hospital New Orleans
New Orleans, LA 70118
Site contact: Carrie Henderson, MD · 504-899-9511 · chend7@lsuhsc.edu
Johns Hopkins University School of Medicine
Baltimore, MD 21287
Site contact: Renee D Boss, MD · 410-614-6444 · rboss1@jhu.edu
Seattle Childrens Hospital
Seattle, WA 98145
Site contact: Holly Vo, MD · 206-884-8355 · Holly.vo@seattlechildrens.org
Study contacts (from the official record)
- Renee D Boss, MD · 4106146444 · rboss1@jhu.edu
- Fiona Jardine, RN · 410-955-5232 · fjardin1@jhu.edu
Similar studies in Florida
All healthy volunteers studies in Florida →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study of LY4302814 in Healthy Participants
Eli Lilly and Company
- Location
- Daytona Beach, FL
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Pfizer
- Location
- Orlando, FL + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Safety and PK Study of BICX104 With or Without Bupropion Compared to Vivitrol
BioCorRx Pharmaceuticals Inc
- Location
- Miami, FL
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234
Arcutis Biotherapeutics, Inc.
- Location
- Miami, FL + 6 other US sites
- Eligibility basics
- Ages 18–65